Stay updated on IBI310 and Siltilimab in NPC Clinical Trial

Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record history shows the revision updated from v3.5.4 to v3.5.5, indicating a new version of the record. This reflects a versioning update rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-08T15:46:45.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision, v3.5.4, is now listed in the Record History, replacing v3.5.3. This update reflects a new release of the study record.
    Difference
    0.1%
    Check dated 2026-05-18T03:53:26.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page’s footer/version label updates from Revision v3.5.2 to Revision v3.5.3, reflecting a site release rather than a change to the clinical trial history information.
    Difference
    0.1%
    Check dated 2026-04-26T08:16:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the study record history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:52:45.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T09:13:08.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page history.
    Difference
    0.1%
    Check dated 2026-03-06T18:23:22.000Z thumbnail image

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.